Victor H Lee

Victor H F Lee

UNVERIFIED PROFILE

Are you Victor H F Lee?   Register this Author

Register author
Victor H Lee

Victor H F Lee

Publications by authors named "Victor H F Lee"

30Publications

692Reads

46Profile Views

1PubMed Central Citations

Molecular subtyping of cancer: current status and moving toward clinical applications.

Brief Bioinform 2019 03;20(2):572-584

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bib/bby026DOI Listing
March 2019

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.

J Clin Oncol 2018 Jul 10:JCO2018777847. Epub 2018 Jul 10.

Anthony T.C. Chan, Edwin P. Hui, Brigette B.Y. Ma, Herbert H.F. Loong, Macy Tong, and Darren M.C. Poon, Prince of Wales Hospital; Roger K.C. Ngan and Hoi C. Cheng, Queen Elizabeth Hospital; Stewart Y. Tung and Frank C.S. Wong, Tuen Mun Hospital; Ashley C.K. Cheng, Princess Margaret Hospital; Wai T. Ng, Pamela Youde Nethersole Eastern Hospital; Victor H.F. Lee, Queen Mary Hospital; and Anthony T.C. Chan, Edwin P. Hui, Brigette B.Y. Ma, Herbert H.F. Loong, Anil T. Ahuja, Ann D. King, Ki Wang, Frankie Mo, Benny C.Y. Zee, K.C. Allen Chan, and Y.M. Dennis Lo, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7847DOI Listing
July 2018

Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.

BMC Cancer 2018 Jul 31;18(1):776. Epub 2018 Jul 31.

Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, 1/F Professorial Block, 102, Pokfulam Raod, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4687-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069713PMC
July 2018

A Novel Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive Genotype Screening.

Front Oncol 2018 24;8:279. Epub 2018 Jul 24.

Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066555PMC
July 2018

Case sharing of a patient re-challenged with afatinib for EGFR-mutated advanced non-small cell lung cancer.

Authors:
Victor H F Lee

Asia Pac J Clin Oncol 2018 Mar;14 Suppl 1:4-6

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12854DOI Listing
March 2018

Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis.

BMC Bioinformatics 2018 Mar 7;19(1):88. Epub 2018 Mar 7.

Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-018-2093-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842518PMC
March 2018

Head and neck cancer in Hong Kong.

Jpn J Clin Oncol 2018 Jan;48(1):13-21

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx151DOI Listing
January 2018

Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations.

Sci Rep 2017 07 26;7(1):6595. Epub 2017 Jul 26.

Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06632-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529360PMC
July 2017

Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Eur Arch Otorhinolaryngol 2017 Feb 13;274(2):1067-1078. Epub 2016 Oct 13.

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, 1/F, Professorial Block, 102 Pokfulam Road, Pokfulam, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-016-4339-0DOI Listing
February 2017

Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.

Am J Clin Oncol 2016 08;39(4):355-62

Departments of *Clinical Oncology †Diagnostic Radiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000070DOI Listing
August 2016

The aftermath of LUX-Lung 7 study-what have we learnt from it?

Authors:
Victor H F Lee

Ann Transl Med 2016 Aug;4(15):294

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.07.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980371PMC
August 2016

Selectivity profile of afatinib for EGFR-mutated non-small-cell lung cancer.

Mol Biosyst 2016 04;12(5):1552-63

Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6mb00038jDOI Listing
April 2016

Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties.

Comput Biol Med 2015 Aug 28;63:293-300. Epub 2014 Jun 28.

Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2014.06.016DOI Listing
August 2015

Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.

Cancer 2015 Aug 6;121(16):2720-9. Epub 2015 May 6.

Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29413DOI Listing
August 2015

Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.

BMC Oral Health 2015 Mar 20;15:39. Epub 2015 Mar 20.

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, 1/F, Professorial Block, Queen Mary Hospital, Pok Fu lam, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12903-015-0023-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381516PMC
March 2015

Novel therapy for nasopharyngeal carcinoma--where are we.

Oral Oncol 2014 Sep 22;50(9):798-801. Epub 2014 Jan 22.

Department of Clinical Oncology, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2014.01.002DOI Listing
September 2014

Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong.

Hong Kong Med J 2014 Jun 22;20(3):178-86. Epub 2013 Nov 22.

Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12809/hkmj133986DOI Listing
June 2014

Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation.

Radiat Oncol 2012 Nov 26;7:199. Epub 2012 Nov 26.

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, Professorial Block, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1748-717X-7-199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573990PMC
November 2012

Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer.

Int J Radiat Oncol Biol Phys 2012 Sep 13;84(1):176-82. Epub 2012 Jan 13.

Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.10.010DOI Listing
September 2012

Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients?

Int J Radiat Oncol Biol Phys 2012 Jun 2;83(2):e213-21. Epub 2012 Mar 2.

Oral Rehabilitation, The University of Hong Kong Faculty of Dentistry, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.12.040DOI Listing
June 2012

Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Int J Radiat Oncol Biol Phys 2010 Jan;76(1):138-45

Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, People's Republic of China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016090061
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2009.01.084DOI Listing
January 2010